- Dr. Fabrice Egros to assume Corporate Development responsibilities as President, Corporate Development & Growth Markets
- Dr. Egros takes over the Corporate Development role from Alan Butcher departing from the Company on February 28, 2022.
- Dr. Egros will lead the development and execution of the Company’s inorganic growth strategy, including mergers and acquisitions, business development, in-licensing arrangements, and related matters. He will continue to lead business in LATAM and Asia regions in this new role.
Lupin Announces Executive Leadership Change
Related Posts
Leave a Reply
Recent News
